Clinical Trials in Nellore

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV

Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1125 matching records held by the registry are in this view. Synced 22 Sep 2026, 03:16 UTC

1125

Studies in scope

all four open statuses

610

Recruiting now

open to new participants

221

Lead sponsors

across recruiting studies

Top sites

New Delhi 17 Ahmedabad 16 Bangalore 15 Nagpur 14 Bhubaneswar 14

Narrow the registerReset

Search within results

Recruitment status

Phase

Lead sponsor

Clear sponsor filter

Site location

All 61 locations

Target enrolment

Status

Study

Lead sponsor

Phase

Enrol

Indian sites

Start

Recruiting

A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting

NCT07613307Diabetes Mellitus, Type 2, Diabetes Melletus, Glucose Metabolism Disorders, Metabolic Disorders

Eli Lilly and Company

Phase 3

130

Agra, Hyderabad, Kanpur, Kolkata, Mumbai, Mysore, Nashik, Nellore

2026-07-15

Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-india/city/nellore

Query this register directly

GET /api/trials?country=in&status=recruiting&format=json Try it now →

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.